Emerging frontiers in epigenetic-targeted therapeutics for pediatric neuroblastoma
Neuroblastoma (NB), the most prevalent extracranial solid malignancy in children, poses significant therapeutic challenges, particularly concerning high-risk subtypes characterized by an immunologically “cold” phenotype. These tumors evade immune surveillance through mechanisms such as impaired anti...
Saved in:
Main Authors: | Xiaokang Wang, Gengrui Xu, Hongyan Ma, Xiaoyan Deng, Guiping Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1637626/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular genetic features of neuroblastoma in adolescent
by: N. A. Andreeva, et al.
Published: (2024-06-01) -
Surgical treatment of retroperitoneal neuroblastoma in children. Clinical experience
by: S. A. Kuznetsov, et al.
Published: (2022-03-01) -
Experience of Neuroblastoma Treatment in Children and Teenagers (Materials of Pediatric Oncology Department of Rostov Cancer Research Institute for 2001–2009)
by: Yu. Yu. Kozel, et al.
Published: (2010-06-01) -
POSTTREATMENT NEUROBLASTOMA MATURATION TO GANGLIONIC CELL TUMOR
by: M. V. Ryzhova, et al.
Published: (2015-04-01) -
Analysis of Pro-Inflammatory and Anti-Inflammatory Cytokine Serum Concentrations in Pediatric Patients with Neuroblastoma: A Preliminary Study
by: Silvia Selene Moreno-Guerrero, et al.
Published: (2025-06-01)